康方生物-B涨近13%破顶 中生制药涨近4%

智通财经网
20 Jan 2021

康方生物-B(09926)与中生制药(01177)共研产品发布最新研究结果。康方生物早盘高开高走,截至发稿,涨12.84%,报55.8港元,成交额1.2亿港元。中生制药涨3.93%,报7.66港元,成交额1.66亿港元。康方生物-B公告显示,公司与中国生物制药有限公司共同开发的抗PD-1单抗药物派安普利(安尼可)(研发代号:AK105)联合安罗替尼一线治疗晚期肝癌(“HCC”)的最新研究在2021...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10